LHC — Q3 2021 Earnings Presentation
48 slides from LHC's earnings presentation, Nov 4, 2021
Slide 1: Supplemental Financial Information Third Quarter Ended September 30, 2021
Supplemental Financial Information Third Quarter Ended September 30, 2021 November 3, 2021 1 Exhibit 99.2
Slide 2: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS This presentation contains “forward-looking statements” (as defined in the Securities Litigation Reform Act of 1995) regarding, among other things, future events or the future financial performance of the Company. Words such as “anticipate,” “expect,” “project,” “intend,”
Slide 3: Table of Contents
TABLE OF CONTENTS Business & Legislative Overview 4 - 11 Differentiated Strategies 12 - 27 2021 Consolidated Results Segment Results Guidance, Liquidity & Outlook Appendix LHC Group Overview Commentary on Q3 2021 and Q4 2021 Trends Choose Home Care Act of 2021 Policies on Home Care Unprecedented Sup
Slide 4: Business & Legislative Overview
BUSINESS & LEGISLATIVE OVERVIEW 4
Slide 5: LHC Group Overview as of November 1, 2021
Home Health Hospice HCBS Home Health & Hospice Home Health & HCBS Home Health, Hospice, & HCBS LHC GROUP OVERVIEW AS OF NOVEMBER 1, 2021 LEGEND: 556 home health locations 167 hospice locations 130 home & community based services locations 12 long term acute care hospital locations 52 other service l
Slide 6: Commentary on Q3 2021 Trends: Hurricane Ida and Delta variant impact
Hurricane Ida and the capacity constraints caused by the Delta variant’s impact on clinicians on quarantine – particularly in the Southeast which comprises two-thirds of total revenue – caused significant headwinds for Q3 compared with Q3 2020 and Q2 2021. A total of 39 home health and three hospice
Slide 7: Commentary on Q3 and Q4 2021 Trends
Momentum from new physician referral sources continues with 4,773 new and unique home health referral sources added in Q3 which is a 4.2% increase over the same period in 2020. Home Health average daily census of 84,258 in Q3 2021 was 2.4% higher than 82,254 in Q3 2020 but down 1.5% sequentially fro
Slide 8: Choose Home Care Act of 2021
For the first time, allows Medicare seniors to choose to recover at home as opposed to an in-patient healthcare facility after a hospitalization and who meet the eligibility for Skilled Nursing Facility (SNF). Introduced July 29, 2021 in the Senate (S-2562) with bipartisan sponsorship led by Sens. S
Slide 9: Policies on Home Care
The Biden administration continues to promote the expansion of home health services, including HCBS services, as a portion of its infrastructure proposal known currently as the American Jobs Plan. Discussion is now ongoing within Congress as to the possible inclusion of this expansion of HCBS servic
Slide 10: Home Health Final Rule for FY22
Home Health Final Rule for FY22 posted on November 2, 2021: No cuts for 2022 and an aggregate increase of payment rates of 2.5% ($445 million) which includes a decrease in payments due to reduction in rural add-on payments mandated by BBA 2018. (The payment update is based on a 3.1% market basket, r
Slide 11: Unprecedented Support for Homecare
UNPRECEDENTED SUPPORT FOR HOMECARE 11 “The Biden-Harris administration recognizes the value and dignity that come with access to home- and community-based services. Thanks to the American Rescue Plan, we can support states working to expand access to home- and community-based services for Medicaid b
Slide 12: Differentiated Strategies
DIFFERENTIATED STRATEGIES 12
Slide 13: Differentiated Strategy Leading to Quality Growth
Joint ventures drive organic growth and margin improvement Same store growth for JV locations averaged 200 basis points higher than non-JV locations for the years 2016-2019. Revenue growth rate for JVs average 10% to 15% in year 2 and 3. Margins for JV locations average 100 to 200 basis points highe
Slide 14: Differentiated Strategy Leading to Quality Growth Continued
Continued focus on quality and patient satisfaction to drive higher referrals Increased new home health physician referral sources by 22.0% in 2020 over 2019; by 23.0% in the first nine months of 2021 as compared to 2020 and by 4.3% in Q3 of 2021. Untapped growth in home health and hospice co-locati
Slide 15: Multiple Organic and Inorganic Growth Levers
MULTIPLE ORGANIC AND INORGANIC GROWTH LEVERS Organic Growth Acquisition Growth Upside Opportunities Move to taking risk on total cost of HH from MA plans and health systems Grow Imperium ACOs and extend proven record of managing post-acute network building Create high performing post-acute networks
Slide 16: Building Blocks of Long-Term Earnings Growth
BUILDING BLOCKS OF LONG-TERM EARNINGS GROWTH Developing alternative reimbursement models (PMPM; Case Rate; episodic) with regional and national payors, demonstrating continued progression beyond fee-for-service and per visit relationships Revising contracts and developing processes with major payors
Slide 17: Recruiting and Retention
RECRUITING AND RETENTION We continue to see positive trends in recruiting and retention. We have three consecutive quarters in which we have hired a record number of employees while our turnover continues to be well below industry averages. Our headcount statistics are a direct correlation and valid
Slide 18: New COVID Cases Declining in Q4 2021
NEW COVID CASES DECLINING IN Q4 2021 18 Source: Center for Systems Science and Engineering at Johns Hopkins University https://systems.jhu.edu/research/public-health/ncov/ The table below illustrates the changes in new COVID cases in the Company’s 1,781 service counties across its 35-state (and Dist
Slide 19: New COVID Cases Declining in Q4 2021 (Southeast)
NEW COVID CASES DECLINING IN Q4 2021 19 Source: Center for Systems Science and Engineering at Johns Hopkins University https://systems.jhu.edu/research/public-health/ncov/ The table below illustrates the changes in new COVID cases in the Company’s 839 service counties across its footprint in 10 Sout
Slide 20: Sequential Operational Trends
SEQUENTIAL OPERATIONAL TRENDS Home Health, Hospice and HCBS Trends 20 * Completed the Heart of Hospice acquisition on September 1, 2021
Slide 21: Home Health and Hospice Clinicians on Quarantine Trend
Home Health and Hospice Clinicians on Quarantine Trend 21
Slide 22: Home Health Labor Cost per Visit
HOME HEALTH LABOR COST PER VISIT 22
Slide 23: Home Health and Hospice Growth
HOME HEALTH AND HOSPICE GROWTH Same Store Organic Admission Growth over Prior-Year Periods Sequential Same Store Organic Admission Growth New Physician Home Health Referral Sources 23
Slide 24: Industry-Leading Quality and Patient Satisfaction
INDUSTRY-LEADING QUALITY AND PATIENT SATISFACTION 85% of LHC Group same-store providers have CMS 4 stars or greater for quality 100% of LHC Group home health and hospice agencies are Joint Commission accredited or are in the accreditation process within 12 to 18 months after acquisition. Approximate
Slide 25: M&A Activity Sets the Stage for 2022 Growth
M&A ACTIVITY SETS THE STAGE FOR 2022 GROWTH The acquired annual revenue of approximately $300 million for 2021 would contribute in the range of $20 million to $25 million in EBITDA to 2022. 25
Slide 26: HCI Segment Strongly Supports Advanced Care@Home Programs
LHCG’s unique value-based assets are fully on display with SCP Health’s national team of 7,500 emergency department physicians and hospitalists Imperium Health – ACO ownership, management and enablement Advanced Care House Calls – primary care services Long Term Solutions – elder care guidance CareJ
Slide 27: Advanced Care@Home Partnership with SCP Health
765 current collective hospital partnerships 70 existing hospitals in which both LHC Group and SCP Health have partnerships 109 additional hospitals in which SCP Health is partnered and LHC Group operates a home health agency in the market Over 20 million combined patient encounters annually ADVANCE
Slide 28: 2021 Consolidated Results
2021 CONSOLIDATED RESULTS 28
Slide 29: 2021 Adjusted Consolidated Results
2021 ADJUSTED CONSOLIDATED RESULTS 29
Slide 30: Adjusted Consolidated Results – 2021 vs 2020
ADJUSTED CONSOLIDATED RESULTS – 2021 VS 2020 30
Slide 31: Adjustments to Net Income
ADJUSTMENTS TO NET INCOME *See footnotes on page 32 31
Slide 32: Adjustments to Net Income Continued
ADJUSTMENTS TO NET INCOME CONTINUED Expenses and other costs associated with recently announced or completed acquisitions, de novos and legal expenses ($9.4 million and $14.1 million pre-tax in the three and nine months ended September 30, 2021, respectively; $2.5 million and $4.6 million pre-tax in
Slide 33: Segment Results
SEGMENT RESULTS 33
Slide 34: Three Months Ended Sep. 30, 2021 Adjusted Segment Results
THREE MONTHS ENDED SEP. 30, 2021 ADJUSTED SEGMENT RESULTS 34
Slide 35: Nine Months Ended Sep. 30, 2021 Adjusted Segment Results
NINE MONTHS ENDED SEP. 30, 2021 ADJUSTED SEGMENT RESULTS 35
Slide 36: Home Health Segment Adjusted Segment Results – 2021 vs 2020
HOME HEALTH SEGMENT ADJUSTED SEGMENT RESULTS – 2021 VS 2020 36 For the three months ended September 30, 2021, Revenue increased by $13 million or 3.5% as compared to Q3 2020. The increase is due to a 2.4% increase in census, coupled with an increase in Revenue per Completed Medicare Episode of appro
Slide 37: Hospice Segment Adjusted Segment Results – 2021 vs 2020
HOSPICE SEGMENT ADJUSTED SEGMENT RESULTS – 2021 VS 2020 37 For the three months ended September 30, 2021, Revenue increased $22.9 million and EBITDA increased $3.1 million. The increase in revenue is due to approximately $21 million of inorganic revenue from recent acquisitions, approximately $1 mil
Slide 38: Home and Community Based Services Segment Adjusted Results – 2021 vs 2020
HOME AND COMMUNITY BASED SERVICES SEGMENT ADJUSTED SEGMENT RESULTS – 2021 VS 2020 38 For the three months ended September 30, 2021, Net Service Revenue decreased $2.6 million or 5.3% as compared to Q3 2020. The decrease in revenue is due to a 6.4% decline in billable hours owing to ongoing staffing
Slide 39: Facility-Based Services Segment Adjusted Results – 2021 vs 2020
FACILITY-BASED SERVICES SEGMENT ADJUSTED SEGMENT RESULTS – 2021 VS 2020 39 Facility-Based Revenue decreased $0.9 million or 2.8% as compared to Q3 2020, driven by a 2.4 day decrease in average length of stay. The impact to patient days of the lower average length of stay was partially offset by a 2.
Slide 40: Health Care Innovations Segment Adjusted Results – 2021 vs 2020
HEALTH CARE INNOVATIONS SEGMENT ADJUSTED SEGMENT RESULTS – 2021 VS 2020 The increase in revenue and EBITDA in the third quarter of 2021, as compared to the third quarter of 2020, is due to the receipt of a higher Medicare Shared Savings Payment (MSSP) of $11.7 million in the current quarter as compa
Slide 41: Guidance, Liquidity & Outlook
GUIDANCE, LIQUIDITY & OUTLOOK 41
Slide 42: Full Year 2021 Guidance
Assumptions Guidance updated for extension of the Public Health Emergency through January 16, 2022. Estimated effective tax rate of 25.5% to 26.0% for full year 2021. 5% to 7% organic growth in home health admissions for the year; 2% to 4% organic growth in hospice admissions for the year. Gross mar
Slide 43: Debt and Liquidity Metrics
DEBT AND LIQUIDITY METRICS 43
Slide 44: Appendix
APPENDIX 44
Slide 45: Non-GAAP Reconciliations
NON-GAAP RECONCILIATIONS (Amounts in thousands, unaudited) *Footnotes are on page 48 45
Slide 46: Non-GAAP Reconciliations
NON-GAAP RECONCILIATIONS (Amounts in thousands, unaudited) *Footnotes are on page 48 46
Slide 47: Non-GAAP Reconciliations: Adjusted EBITDA
NON-GAAP RECONCILIATIONS (Amounts in thousands, unaudited) Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) Expenses and other costs associated with recently announced or completed acquisitions and de novos ($2.1 million pre-tax in the three and six months en
Slide 48: It all about helping people.
It all about helping people.